Skip to Content

Glaxo 387 (Ceftin 250 mg)

Generic Name: cefuroxime

Pill imprint Glaxo 387 has been identified as Ceftin 250 mg.

Ceftin is used in the treatment of bacterial infection; urinary tract infection; bladder infection; sinusitis; skin and structure infection (and more), and belongs to the drug class second generation cephalosporins. There is no proven risk in humans during pregnancy. Ceftin 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ceftin 250 mg Glaxo 387 Front
Ceftin 250 mg Glaxo 387 Back
Ceftin 250 mg Glaxo 387
Discount Card Promo
Ceftin
Generic Name:
cefuroxime
Imprint:
Glaxo 387
Strength:
250 mg
Color:
Blue
Size:
15.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Second generation cephalosporins
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
GlaxoSmithKline
National Drug Code (NDC):
00173-0387
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
hypromelloses
methylparaben
microcrystalline cellulose
propylene glycol
propylparaben
sodium benzoate
sodium lauryl sulfate
titanium dioxide

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide